Lyra Therapeutics News

HC Wainwright & Co. Reiterates Neutral on Lyra Therapeutics, Maintains $2 Price Target

BenzingaAug 15 07:05 ET

Lyra Therapeutics Analyst Ratings

BenzingaAug 15 07:02 ET

BTIG Maintains Lyra Therapeutics(LYRA.US) With Hold Rating

Moomoo NewsAug 15 06:31 ET

Lyra Therapeutics Analyst Ratings

BenzingaJun 20 13:40 ET

Jefferies Cuts Lyra to Hold in Wake of Failed Phase 3 Study

Seeking AlphaMay 7 11:14 ET

Jefferies Downgrades Lyra Therapeutics to Hold, Price Target at $0.50

MT NewswiresMay 7 07:41 ET

Analysts Offer Insights on Healthcare Companies: Lyra Therapeutics (LYRA), Bristol-Myers Squibb (BMY) and Axsome Therapeutics (AXSM)

TipRanksMay 7 05:25 ET

Sell Rating on Lyra Therapeutics Amid Phase 3 Study Failure and Funding Concerns

TipRanksMay 7 05:21 ET

BTIG Downgrades Lyra Therapeutics (LYRA) to a Hold

TipRanksMay 6 11:00 ET

Buy Rating Affirmed for Lyra Therapeutics Amid Strong Phase 3 Prospects for LYR-210

TipRanksMay 2 08:26 ET

Lyra Therapeutics Analyst Ratings

BenzingaMay 1 06:33 ET

Buy Rating for Lyra Therapeutics Backed by Upcoming Catalysts and Market Potential

TipRanksMay 1 06:21 ET

Buy Rating Affirmed for Lyra Therapeutics Amid Favorable LYR-210 Trial Outcomes and Strategic CRS Market Positioning

TipRanksMay 1 06:21 ET

Lyra Therapeutics Analyst Ratings

BenzingaApr 17 09:36 ET

Lyra Therapeutics Analyst Ratings

BenzingaMar 25 06:48 ET

Lyra Therapeutics Analyst Ratings

BenzingaMar 22 06:41 ET

Optimistic Buy Rating for Lyra Therapeutics' LYR-210 Amidst Phase 3 Trial and Market Opportunity

TipRanksMar 22 06:25 ET

BTIG Keeps Their Buy Rating on Lyra Therapeutics (LYRA)

TipRanksJan 2 09:30 ET

Lyra Therapeutics' Nasal Implants Show Promising Results: A Buy Rating Supported by Phase 2 BEACON Trial and Upcoming Phase 3 ENLIGHTEN Trial

TipRanksNov 9, 2023 06:32 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Vericel (VCEL), Sana Biotechnology (SANA) and Lyra Therapeutics (LYRA)

TipRanksNov 9, 2023 06:31 ET